Medical News

RSS

Efforts to expand adult day care programs threatened by recession-driven cuts

Kaiser Health News, in a story produced in collaboration with The Washington Post, reports on adult day care.

2 Dec 2009

Generic erosion to decrease branded atypical antipsychotics schizophrenia drug market to $5.2B

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that generic erosion of several established branded atypical antipsychotics will cause the schizophrenia drug market to decrease from $6.3 billion in 2008 to $5.2 billion in 2013 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.

2 Dec 2009

Minnesota's first e-Patient

Minnesota's first virtual doctor's visit was conducted Monday evening, the Pioneer Press reports. The patient, Beth Piper or Hampton, Minn., learned that sleeping pills would interact badly with another medication she uses during the seven minute Webcam-enabled discussion. Her doctor, Eric Christianson, suggested using Benadryl instead.

2 Dec 2009

Genta to supply Ganite for new CF clinical trial

Genta Incorporated announced that the Company will supply Ganite® (gallium nitrate injection) for a new clinical trial that will be initiated in patients with cystic fibrosis (CF) who may develop serious infections.

2 Dec 2009

Health bill's lesser-known provisions could have big impact

News outlets report on some of the lesser-known provisions of the health care bills pending in Congress, including possible improvements for the Indian Health System and mandated calorie count labels on vending machines.

2 Dec 2009

Shire settles ADDERALL XR authorized generic version supply litigation

Shire plc, the global specialty biopharmaceutical company, announces that it has settled the litigation with Teva Pharmaceuticals USA, Inc. ("Teva") over Shire's supply to Teva of an authorized generic version of ADDERALL XR. Shire has been supplying Teva with authorized generic ADDERALL XR since April 1, 2009.

2 Dec 2009

Online medical pricing takes on new importance in struggling economy

"Consumers are increasingly turning to the Web to compare medical fees as the economy and less generous health benefits squeeze household budgets," The Associated Press reports. Their efforts are aided in many states by laws that require online posting of medical fees. "More than 30 states have passed laws that require online publication of medical fees by hospitals and other health care providers," according to the AP.

2 Dec 2009

TARIS Biomedical completes Phase 1 study of its intravesical drug-device convergence system

TARIS Biomedical, a specialty pharmaceutical company pioneering the field of drug-device convergence for targeted therapies, announced today the successful completion of a Phase 1 clinical study of its intravesical drug-device convergence system designed to provide sustained-release of drug directly to the bladder.

2 Dec 2009

World’s first 1000 MHz ultra-high field NMR AVANCE spectrometer installed at CRMN, France

Bruker BioSpin has successfully completed the installation of the world’s first 1000 MHz ultra-high field NMR AVANCE™ spectrometer at the Centre de Resonance Magnétique Nucléaire à Très Hauts Champs (CRMN) in Lyon, France (a joint research unit of CNRS, Ecole Normale Supérieure de Lyon and Université Lyon 1).

2 Dec 2009

Capsule launches first intelligent touch-screen platform to manage bedside device connectivity

Capsule, the leading provider of medical device connectivity, today announced its official release of the Capsule Neuron™. Following Capsule's recent release of their Enterprise Device Connectivity Solution, the flexible, innovative Capsule Neuron platform allows the solution to be deployed across the hospital in both high and low acuity environments.

2 Dec 2009

Accera Pharmaceuticals to implement the Veeva CRM suite of multi-tenant SaaS applications

Less than 9 months after implementing a new CRM application, Accera Pharmaceuticals began searching for a replacement. The commercial-stage biotechnology company, which launched Axona™ (a prescription-only medical food for the clinical dietary management of the metabolic processes associated with mild-to-moderate Alzheimer's disease) around the same time as it implemented its current system, had quickly outgrown the generic CRM tool.

2 Dec 2009

S*BIO to present data on its novel oral JAK2 inhibitor at The American Society of Hematology meeting

S*BIO Pte Ltd today announced data presentations on its novel oral JAK2 inhibitor, SB1518, at The American Society of Hematology 51st Annual Meeting and Exposition in New Orleans.

2 Dec 2009

Sepracor to present clinical study data of STEDESA at the 2009 AES meeting

Sepracor Inc. today announced that clinical study data for STEDESA™ (eslicarbazepine acetate) will be presented at the 2009 annual meeting of the American Epilepsy Society (AES) in Boston. Seven posters describing new safety analyses will be presented at the Hynes Convention Center during the formal poster session on Saturday, December 5, 2009 between 1:00 pm and 8:00 pm EST.

2 Dec 2009

Positive results from DermaGen's Phase I/IIa AMP study of atopic dermatitis

DermaGen AB - part of the Karolinska Development dermatology and wound healing company "Pergamum" - announced that Dermagen AB has received promising results from a clinical Phase I/IIa study. DermaGen AB is developing a novel antimicrobial peptide (AMP) treatment for atopic dermatitis. Atopic dermatitis is a chronic inflammatory skin disease where dry skin and the skin's weakened barrier function make patients susceptible to colonization by microorganisms, a triggering or exacerbating factor of the disease.

2 Dec 2009

NHLBI awards stimulus funds for hemophilia drug research

PTC Therapeutics, Inc. (PTC) today announced the receipt of a $1 million Challenge Grant award from the National Heart, Lung, and Blood Institute (NHLBI) as part of the National Institutes of Health (NIH).

2 Dec 2009

IDN Health Systems implements PHACTS' Enterprise-Wide Inventory Management Solution

PHACTS, LLC, a leader in Pharmacy Inventory Management Systems, signed exclusive agreements in 2009 with USA IDN Health Systems and hospitals valued at $22.4 million in new business. PHACTS expects this number to grow to over $30 million by the end of 2009.

2 Dec 2009

International AIDS Vaccine Initiative calls for redoubled efforts in vaccine development

As we approach World AIDS Day, observed globally December 1, we are reminded that while progress has been made in expanding access to treatment and prevention and that progress has been made toward the development of new prevention tools, the world is still falling short of established targets for providing universal access to HIV and AIDS prevention, treatment and care by 2010. Nearly 5.5 million of the estimated 9.5 million people in need of antiretroviral therapy are still not receiving it.

2 Dec 2009

Protein marker may hold the key against pancreatic cancer

Pancreatic tumors can be identified by a readily detectable marker that shows promise as a basis for immune therapy against the disease, according to research at Washington University School of Medicine in St. Louis.

2 Dec 2009

Worldwide DRTV marketing of BioElectronics' ActiPatch and Allay brands

BioElectronics Corp., the maker of inexpensive, disposable drug-free anti-inflammatory devices, today announced the details of its worldwide Direct Response Television (DRTV) strategy to further enhance its international marketing efforts for its award-winning, pain relieving ActiPatch and Allay brands. The Company will launch campaigns in Latin America beginning in December, Canada in January, Europe and Australia in the first quarter and is currently in process of negotiating a partnership to enter the lucrative Japanese market.

2 Dec 2009

BC's Ministry of Health cuts funds for HIV and AIDS service organizations

Today, as local and national governments around the world reaffirm their commitment to continue the fight against HIV and AIDS, BC's government is doing the opposite.

2 Dec 2009

Medical News

Efforts to expand adult day care programs threatened by recession-driven cuts

Generic erosion to decrease branded atypical antipsychotics schizophrenia drug market to $5.2B

Minnesota's first e-Patient

Genta to supply Ganite for new CF clinical trial

Health bill's lesser-known provisions could have big impact

Shire settles ADDERALL XR authorized generic version supply litigation

Online medical pricing takes on new importance in struggling economy

TARIS Biomedical completes Phase 1 study of its intravesical drug-device convergence system

World’s first 1000 MHz ultra-high field NMR AVANCE spectrometer installed at CRMN, France

Capsule launches first intelligent touch-screen platform to manage bedside device connectivity

Accera Pharmaceuticals to implement the Veeva CRM suite of multi-tenant SaaS applications

S*BIO to present data on its novel oral JAK2 inhibitor at The American Society of Hematology meeting

Sepracor to present clinical study data of STEDESA at the 2009 AES meeting

Positive results from DermaGen's Phase I/IIa AMP study of atopic dermatitis

NHLBI awards stimulus funds for hemophilia drug research

IDN Health Systems implements PHACTS' Enterprise-Wide Inventory Management Solution

International AIDS Vaccine Initiative calls for redoubled efforts in vaccine development

Protein marker may hold the key against pancreatic cancer

Worldwide DRTV marketing of BioElectronics' ActiPatch and Allay brands

BC's Ministry of Health cuts funds for HIV and AIDS service organizations

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Latest News